Concerning RTK, Arpel et al. (28) showed that small peptides interfering with the TM domain of ErbB2 inhibit breast tumor growth and metastasis when used at micromolar concentrations in a mouse model of breast cancer. The gene discussed is ERBB2; the disease is breast cancer.